Search
for
Sort by
Research 30 of 132
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Cutaneous Reactions to Drugs
- Dermatological Manifestations of COVID-19: A Brief Review
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations
- Maculopapular Drug Eruption Caused by Finasteride: A Case Report
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- COVID-19 and Autoimmunity in Dermatology: A Moroccan Case Series and Literature Review
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Toxic shock syndrome: Recent developments in pathogenesis
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- Cutaneous drug reactions
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Cutaneous manifestations of COVID-19
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Severe cutaneous adverse reactions to drugs
- Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Cutaneous manifestations of COVID-19: a systematic review and analysis of individual patient-level data
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Psychoactive drugs and skin
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature